DARPins against a functional IgE epitope (Q39673348)

13 September 2017

title

DARPins against a functional IgE epitope (English)

1 reference

13 September 2017

2

Alexander Eggel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20673836

14 June 2024

author name string

Patrick Amstutz

3

1 reference

13 September 2017

Monique Vogel

5

1 reference

13 September 2017

Michael J. Baumann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20673836

14 June 2024

Beda M. Stadler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20673836

14 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20673836

14 June 2024

publication date

29 July 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0165247810001926?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

https://api.elsevier.com/content/article/PII:S0165247810001926?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

14 June 2024

1 reference

13 September 2017

volume

133

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

78-84

1 reference

Association of asthma with serum IgE levels and skin-test reactivity to allergens

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Biological function of gamma E antibodies and mechanisms of reaginic hypersensitivity

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Predictive values of cord blood IgE and cord blood lymphocyte responses to food antigens in allergic disorders during infancy

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Biological activities of anti-IgE antibodies.

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Therapeutic potential of anti-IgE antibodies

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Asthma treatment: 'magic bullets which seek their own targets'.

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Blocking of passive sensitization of human mast cells and basophil granulocytes with IgE antibodies by a recombinant human epsilon-chain fragment of 76 amino acids

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

The mast cell binding site on human immunoglobulin E

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

The pharmacological basis of anti-IgE therapy

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Effect of anti-IgE therapy in patients with peanut allergy

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

The importance of IgE antibody levels in anti-IgE treatment

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma

14 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Engineered antibody fragments and the rise of single domains

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Engineering novel binding proteins from nonimmunoglobulin domains

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins.

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage.

14 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Isolation of intracellular proteinase inhibitors derived from designed ankyrin repeat proteins by genetic screening

14 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Selection and characterization of Her2 binding-designed ankyrin repeat proteins

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

A designed ankyrin repeat protein evolved to picomolar affinity to Her2

14 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Potential applications of designed ankyrin repeat proteins in diagnostics and therapeutics

14 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

High-affinity binders selected from designed ankyrin repeat protein libraries

14 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

In vitro selection and evolution of functional proteins by using ribosome display

14 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Human anti-IgE antibodies by repertoire cloning

14 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Culture and IgE synthesis of nasal B cells

14 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

An unusual case of IgE myeloma

14 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

A hapten-specific chimaeric IgE antibody with human physiological effector function.

14 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Human IgE synthesis in vitro. Detection with monoclonal antibodies

14 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Characterization of Monoclonal Antibodies Directed Against the α-Subunit of the Human IgE High-Affinity Receptor

14 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target

14 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Human IgE mediates stimulus secretion coupling in rat basophilic leukemia cells transfected with the α chain of the human high‐affinity receptor

14 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

A High-Affinity Natural Autoantibody from Human Cord Blood Defines a Physiologically Relevant Epitope on the Fc RI

14 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Binding of cynomolgus monkey IgE to a humanized anti-human IgE antibody and human high affinity IgE receptor

14 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab

14 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Inhibition of IgE-receptor interactions

14 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Can anti-IgE be used to treat allergy?

14 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies

14 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Molecular basis for nonanaphylactogenicity of a monoclonal anti-IgE antibody

14 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Prediction of an anti-IgE binding site on IgE.

14 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Anti-immunoglobulin E (omalizumab) therapy in allergic asthma

14 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma

14 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

The intrinsic flexibility of IgE and its role in binding FcepsilonRI.

14 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

The key role of protein flexibility in modulating IgE interactions

14 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.IMLET.2010.07.005

14 June 2024

Identifiers

1 reference

13 September 2017

1 reference